We are pleased to welcome Candyce Hamel and Kylie Hunter to the Cochrane Methods Executive.
Candyce is a co-convenor of the Rapid Review Methods Group, an associate convenor of the Artificial Intelligence Methods Group, and works as a Senior Clinical Research Associate at the Ottawa Hospital Research Institute, Canada. Her research focuses on rapid review and systematic review methodology (e.g., AMSTAR, AMSTAR-2) and conducting evidence syntheses, including systematic reviews, scoping reviews, and rapid reviews. She has also worked in guideline development. She has recently co-developed Cochrane’s Interactive Learning module on rapid reviews.
Kylie is associate convenor of the Prospective Meta-Analysis Methods Group and a Research Fellow and co-lead of Evidence Integration at the NHMRC Clinical Trials Centre, University of Sydney, Australia. Her research focuses on advancing collaborative methodologies to improve the quality and trustworthiness of evidence synthesis – particularly individual participant data meta-analysis, prospective meta-analysis, data integrity, trial registration, evidence appraisal, data sharing, and information retrieval. Kylie applies these methods to generate robust evidence addressing high-priority research questions, with a focus on child health.
Kylie also serves on the Board of the Association for Interdisciplinary Meta-Research & Open Science (AIMOS) and is an Advisory Group Member for the Evidence Synthesis Taxonomy Initiative (ESTI).
There were two open positions on the Methods Executive. Carl Moons (Prognosis), Tianjing Li (Comparing Multiple Interventions), and Jane Noyes (Qualitative and Implementation) will rotate off at the end of 2025.
Please join us in welcoming Candyce and Kylie to the Methods Executive and thanking Carl Moons, Tianjing Li, and Jane Noyes for their valuable contributions over the years!
